Popular Articles

Reliance Life IPO likely in Q1 of next fiscal: Ghosh
Anil Ambani Group"s life insurance venture Reliance Life expects to tap the capital market with its initial public offer in the first quarter of next fiscal, a top company official said here.

Bankers will remain bankers
We are always better analysts with a 20/20 hindsight. Indeed, an ex post reading about events leading up to a crisis appears logical, and often leaves one with the question about why the evolution of the crisis could not be seen and corrected in time. Still, policy-makers know that such a review and understanding are important to learning from mistakes. Restoring Financial Stability (Wiley) acts as a catalyst to that understanding by offering a comprehensive sequencing of the causes and progression of the build-up of the financial strains that, following the Lehman bust in September 2008, evolved into a full-blown global financial crisis. It is a collection of thematic essays by the faculty of the Stern School of Business at New York University.

News of the day

Higher project costs force IOC to raise capex by 22%
Spending target raised to Rs 53,000 crore for 2007-12.
Online Business

Wockhardt gets award for patents

Drug maker Wockhardt today said it has been chosen as the pharmaceutical company for the maximum number of patent filings and grants from India. - 'Over 3,000 people will be a part of Fortis' - Wockhardt shareholders approve sale of two biz for Rs 281.6 cr - India Inc takes the sale route to beat crisis - Twice bitten, ready for more - Newsmaker: Shivinder mohan singh">Newsmaker: Shivinder mohan singh - Wockhardt divested to infuse cash for its pharma chain Wockhardt has been granted 70 patents, 15 from the Indian Patent office and 55 from the American and European Patent offices, the drug maker said in a statement. The Minister for Commerce & Industry Anand Sharma will present the award, which has been instituted by the government of India tomorrow in Hyderabad. "This award is a recognition of Wockhardt"s robust, resilient and uncompromising intellectual pursuit in discovering new ways and methods of medical innovation," the company"s Chairman Habil Khorakiwala said.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):